The effect of soy protein on serum lipids in kidney transplant patients receiving rapamycin
| dc.contributor.author | Hanawalt, Elizabeth | |
| dc.contributor.committeeChair | Radcliffe, John | |
| dc.contributor.committeeMember | Illegible | |
| dc.contributor.committeeMember | Illegible | |
| dc.date.accessioned | 2023-12-05T14:58:56Z | |
| dc.date.available | 2023-12-05T14:58:56Z | |
| dc.date.issued | 2001-12 | |
| dc.description.abstract | Rapamycin, a recently approved immunosuppressant, is widely used in patients undergoing a kidney transplant. A considerable drawback to the use of rapamycin is that it can cause an elevation in serum levels of triglycerides (TG) and cholesterol. A study was carried out to determine if a liquid formula containing soy protein, as opposed to one with casein, would lower serum lipids in kidney transplant patients. In a cross-over design, 10 subjects were given either a soy formula or a casein formula for 2 months and then the other formula for 2 months, with a 2 month washout period. The type of formula had no effect on serum levels of cholesterol, high-density lipoprotein, low-density lipoprotein, or TG. Thus, soy protein was not effective in lowering serum lipids in this population. | |
| dc.identifier.uri | https://hdl.handle.net/11274/15600 | |
| dc.language.iso | en_US | |
| dc.subject | Soy protein | |
| dc.subject | Kidney transplant | |
| dc.subject | Rapamycin | |
| dc.title | The effect of soy protein on serum lipids in kidney transplant patients receiving rapamycin | |
| dc.type | Thesis | |
| thesis.degree.college | College of Health Sciences | |
| thesis.degree.department | Nutrition and Food Sciences | |
| thesis.degree.discipline | Nutrition | |
| thesis.degree.grantor | Texas Woman's University | |
| thesis.degree.level | Master | |
| thesis.degree.name | Master of Science |